Jessica Zalapa

🇲🇽| Internal Medicine | Hematology fellow @incmnszmx

[INCMNSZ @incmnszmx]

El INCMNSZ felicita a la Dra. María Roberta Demichelis Gómez por su nombramiento como Jefa del Departamento de Hematología y Oncología.

[Jessica Zalapa @JessicaZaS]

8/ 🧩 Conclusion:
PIRs tailored for local settings, like mCALGB, are game-changers for AYA ALL in LMICs. This study underscores the importance of context-appropriate adaptations in global hematólogo.

[Jessica Zalapa @JessicaZaS]

1/ 📢 Let’s dive into a crucial topic in #Hematology: How do adult regimens compare with pediatric-inspired regimens (PIRs) for Philadelphia-negative ALL? Our study from Mexico offers some insights #ALL

@RobertaDemiche3 @faustor @rajuan_27 @analymorac

https://t.co/b8ydOWFbg5

[Jessica Zalapa @JessicaZaS]

7/ 🚧 Challenges:
•Need for data on Ph-like ALL in Hispanic populations
•Limited access to stem cell transplant and novel therapies like blinatumomab in LMICs

[Juan Luis Ontiveros, MD @JuanLmd]

So glad to see the results of PI regimens implementation in our country by @RobertaDemiche3. Important data that encourages ALL research in LATAM @SocietyofHemOnc.

[Jessica Zalapa @JessicaZaS]

A comparative study of Hyper-CVAD and mCALGB-10403 in adults with Ph negative ALL 🩸#ASH23 My first ASH as hematology resident, such a great experience @ASH_hematology thanks to my mentor and the entire work team @RobertaDemiche3 @faustor @analymorac

[Roberta Demichelis @RobertaDemiche3]

Very proud of our mexican internal medicine and hematology residents/fellows presenting at #ASH22! @yadithlopezz @IsRubens @JessicaZaS. @EliaApodaca @zapata_nidia @GomezDLeonMD @rajuan_27 @internalincmnsz @HemOncINCMNSZ @ContactoAmeh

[Juan Rangel MD @rajuan_27]

Hoy es el día de tomar conciencia sobre Leucemia Mieloide Aguda (LMA) 🩸🧬🔬💊

Aquí algo de información sobre cómo ha avanzado el diagnóstico y tratamiento en los últimos años 👇🏼

#AML #hematology #KnowAML #Hematologia #leucemia #Cancer @ASH_hematology

[Alejandro Macias @doctormacias]

Es justo y necesario. La vacuna covid que está llegando a México es escasa; debe aplicarse con prioridad al personal de salud que está atendiendo a los pacientes con Covid.